Evaluation of IVF Outcomes in Patients with Decreased Ovarian reserve with Double Stimulation Compared with conventional Antagonist Cycle

Evaluation of IVF Outcomes in Patients with Decreased Ovarian reserve with Double Stimulation during Follicular and Luteal Phase Compared with conventional Antagonist Cycle

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120817010617N8

Enrollment

Registered

2021-07-21

Start date

2021-07-11

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: Double Stimulation, Patient's receipt HMG and FSH from day 2 and then when the follicle is upper 13-millimeter cetrotide is consumed and when the follicle is upper

Eligibility

Sex/Gender

Female

Age

No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Patients with reduced ovarian reserve who are candidates for IVF. Endometriosis less than grade 3. No contraindications to use of ovarian stimulation medications. At the same time, the patient's partner should not have azoospermia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total oocyte recovery rate. Timepoint: After oocyte retrieval. Method of measurement: Via Ultrasound Sonography.;The mean Metaphase II (MII) oocyte counts. Timepoint: Oocyte pick up day. Method of measurement: Microscopic assay.;The number of fetus. Timepoint: After puncture. Method of measurement: Microscopic assay -The number of fetuses after injection.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Qahqaei

Zahedan University of Medical Sciences

morimedico@yahoo.com+98 54 3329 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026